Top Markets
Coin of the day
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
주식 순위 #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
주가
$0.21483059
마지막 동기화: 2024-05-07
시가총액
$11.13M
변동 (1일)
0.34%
변동 (1년)
0.00%
국가
CA
거래 Antibe Therapeutics Inc. (ATE)

카테고리

Antibe Therapeutics Inc. (ATE)의 주가 이력
최고 종가: $0.21 (2024-05-01 기준)

최저 종가: $5.29 (2013-06-01 기준)
Antibe Therapeutics Inc.의 주가 이력 (2013 ~ 2026)
연간 주가 성과
연도 성과
2024 -64.54%
2023 70.18%
2022 -33.02%
2021 -82.13%
2020 -5.82%
2019 63.59%
2018 69.29%
2017 -9.13%
2016 -2.14%
2015 -69.92%
2014 -18.37%
2013 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$110.69 -15.03%
US
$331.82 -13.05%
US
$90.44 -2.55%
IE
$51.45 -50.08%
US
$90.82 15.99%
US